Activities, Bill Numbers and Titles
|
|
Client: Boehringer Ingelheim Pharmaceuticals, Inc.
|
|
House Bill
|
4910
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$153.08
|
N/A
|
Senate Bill
|
2520
|
An Act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$153.08
|
N/A
|
House Bill
|
953
|
An Act relative to consumer deductibles
|
Support
|
$153.08
|
N/A
|
House Bill
|
4891
|
An Act promoting access and affordability of prescription drugs
|
Neutral
|
$153.08
|
N/A
|
House Bill
|
3587
|
An Act to ensure access to prescription medications
|
Neutral
|
$153.08
|
N/A
|
Senate Bill
|
580
|
An Act further protecting research animals
|
Neutral
|
$153.08
|
N/A
|
House Bill
|
850
|
An Act concerning the use of animals in product testing
|
Neutral
|
$153.08
|
N/A
|
Senate Bill
|
3012
|
An act relative to pharmaceutical access, costs and transparency
|
Neutral
|
$153.08
|
N/A
|
| | |
Total amount
|
$1,224.64
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
No campaign contributions were filed for this disclosure reporting period. |
|